Rohini Kedare

QC Executive at Marvel Drugs - Navi Mumbai, Maharashtra, India

Rohini Kedare's Colleagues at Marvel Drugs
Shilpa Kadam

Senior Executive Administrative

Contact Shilpa Kadam

Rohini Kedare's Contact Details
HQ
Location
Maharashtra,India
Company
Marvel Drugs
Rohini Kedare's Company Details
Marvel Drugs logo, Marvel Drugs contact details

Marvel Drugs

Navi Mumbai, Maharashtra, India • 19 Employees
Pharmaceuticals

Marvel Drugs Pvt. Ltd. is a fast growing 20+ year old company, offering CRAMS for APIs. We have two FDA approved plants at Taloja, on the outskirts of Mumbai, and operate with ISO 9001:2008 certification. While the majority of our customers are in Europe, we are growing our client base in South America and Africa as well. We are en route to achieve WHO-GMP certification by this financial year, which will open up new markets and molecules for growth. Marvel Drugs is into synthesis of niche APIs. It excels in production of multi step complex molecules. R & D and Quality are two areas of strength, which the company prides itself on. We target development and commercial launch of 1-2 major new molecules a year. The Board of Directors comprises of Nikhil Shah, and Abhishek Shah Since 2014, the company has embarked upon an ambitious goal for growth. For that, we are looking out for world class talent who is hungry and eager to be part of that journey. Our goal is to become one of the top 25 players in CRAMS in India, in the next 10 years

Details about Marvel Drugs
Frequently Asked Questions about Rohini Kedare
Rohini Kedare currently works for Marvel Drugs.
Rohini Kedare's role at Marvel Drugs is QC Executive.
Rohini Kedare's email address is ***@marveldrugs.com. To view Rohini Kedare's full email address, please signup to ConnectPlex.
Rohini Kedare works in the Pharmaceuticals industry.
Rohini Kedare's colleagues at Marvel Drugs are Dilip More, Suraksha Patil, Deeplaxmi Shewale, Shilpa Kadam, Prathamesh Kasekar and others.
Rohini Kedare's phone number is
See more information about Rohini Kedare